online | memorias.ioc.fiocruz.br Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 106(5): 632-634, August 2011 Brazil has the second highest prevalence of leprosy in the world (WHO 2010) . The state of Mato Grosso (MT) has a leprosy prevalence that is three times higher than that of other Brazilian states. In some regions of MT the incidence is increasing (Magalhães & Rojas 2005) .
Chronic viral hepatitis caused by viruses B (HBV) and C (HCV) is an important public health problem. These two viruses are responsible for a great proportion of cases of cirrhosis and hepatocellular carcinoma. Some of the HBV hyperendemic areas in Brazil are also located in MT (Souto 2004) . The HCV infection prevalence is uniform throughout Brazil, ranging from less than 1-2% (Fonseca 1999 , Nascimento et al. 2008 .
Leprosy and viral hepatitis may co-exist in patients from highly endemic areas. It is unknown if injured skin resulting from leprosy may facilitate the spread of bloodborne infectious agents. However, reports such as that by Shiogama et al. (2010) have indicated a progressive increase in the liver-related death rate among inpatients of a Japanese sanatorium and there was a high rate of detection of HCV RNA in liver specimens obtained by necropsy, suggesting that blood-borne hepatitis viruses may circulate at higher rates among these individuals. There are few studies assessing the prevalence of viral hepatitis among leprosy patients in Brazil, but none have been performed in MT (Ottati & Candeias 1979 , Rosa et al. 1992 , 1996 .
The aim of this cross-sectional study was to investigate the prevalence of serologic markers of HBV and HCV in leprosy patients in Várzea Grande, a city with approximately 200,000 inhabitants and one of the highest leprosy prevalence rates in the country.
Patients were selected by consulting of the registry of the Centre for Tropical Diseases, which is the reference centre for the region, between April 2007-January 2009. The patients underwent a structured interview to assess risk factors for viral hepatitis and they had blood samples drawn to perform HBsAg, total anti-HBc, anti-HCV, and anti-HBs tests (Hepanostika Uni-Form for HBsAg and anti-HBc, Hepanostika anti-HCV Ultra, bioMérieux, and Bioelisa anti-HBs, Biokit, respectively).
EpiData software was used to analyse the data (version 3.1). A p value < 0.05 was considered significant. Logistic regression models were constructed using the variables that had significant associations in the univariate analysis. The protocol of the study was approved by the Ethical Research Board of the University Hospital Julio Muller, Cuiabá, MT (protocol 403/CEP-HUJM/07) and all patients signed informed consent forms.
During the study period, 757 outpatients with leprosy were treated. However, 598 could not be contacted. The lack of contact with these patients was mainly due to changes in address or telephone number. Two patients refused to provide blood samples. Although there was a high number of patients who could not be found, these subjects had gender and age distributions similar to those of the patients who were included. In total, 191 patients were included. The mean age was 48 years (range 18-85) and 109 patients (56.5%) were male. One-hundred and eight (56.3%) patients had paucibacillary leprosy and 84 (43.7%) had multibacillary leprosy.
Fifty-three patients [27.7%, 95% confidence interval (CI): 21.9-34.5] had been exposed to HBV (anti-HBc pos- Key words: leprosy -epidemiology -prevalence -hepatitis C -hepatitis B -viral hepatitis itive). Two (1%) out of these were HBV carriers (HBsAg positive). Among the 51 anti-HBc-positive/HBsAg-negative subjects, 44 (86.3%) were also anti-HBs positive. Seven (13.7%) were anti-HBc positive alone. Another 12 (6.3%) patients were positive only for anti-HBs, likely as a consequence of previous vaccination. The risk factor frequencies are shown in Table I . The anti-HBc prevalence was higher than that observed in the general adult population of the Central-West Region of Brazil (10.3%) (Pereira et al. 2009 ). Rosa et al. (1992) found a higher prevalence of HBV markers (50%) in institutionalised patients with leprosy in a region near MT (state of Goiás).
In the multivariate analysis, after adjusting for gender and age group, the use of injecting medications and the number of sex partners were significantly associated with HBV infection (Table II) . Unprotected sexual intercourse with multiple sex partners is likely the most important source of HBV exposure in the general population from adolescence to adulthood (Kane 1990 ). These associations suggest that these subjects were likely infected after childhood, which may explain why the rate of HBV chronification in this sample was low.
Some authors have found a higher prevalence of HBsAg in leprosy patients compared to the general population, especially among lepromatous leprosy patients (Kelkar et al. 1973 , Ottati & Candeias 1979 . These findings prompted the hypothesis that patients with leprosy would have immunological characteristics that would impair the clearance of HBV. In contrast, there also are studies that have shown conflicting results regarding the association of leprosy and chronic viral hepatitis (Sarno et al. 1980 , Fakunle & Whittle 1981 . The heterogeneity of the previous studies partly explains the differing results and prevents us from making definite conclusions.
Because the number of HBV carriers in the present study was low, we cannot conclude if immunosuppression associated with leprosy could facilitate infection with HBV. In this case, it would be expected that immunosuppression also would make chronification more likely, therefore increasing the number of chronically infected HBV subjects. It is more likely that behavioural rather than biological factors facilitated HBV exposure in this patient population.
Five patients were positive for anti-HCV antibodies (2.6%, 95% CI: 1.1-6.0). No variables were found to be associated with the presence of anti-HCV antibodies. Nascimento et al. (2008) showed a prevalence of anti-HCV antibodies up to 1% in blood donors of three Brazilian regions. The present study did not have enough power to draw conclusions about the higher prevalence of HCV exposure among leprosy patients. In addition, a confirmatory test, such as immunoblotting or polymerase chain reaction, was not available in this study. As a consequence, some of the five anti-HCV positive tests could be false-positives, decreasing the prevalence. Furthermore, this study sample included people who were older than would be expected from a randomly selected Brazilian population sample. It is well-known that HCV infection is more common among people over 45 years old. Thus, in the study region, HCV infection does not seem to be more common in leprosy patients than in the general population.
In conclusion, the prevalence of HBV exposure in this sample of leprosy patients was higher than that of the general population in the same region. This higher prevalence was most likely the result of a higher rate of sexual and parenteral exposure. However, the higher prevalence of HBV exposure was not associated with a higher risk of chronic HBV infection, suggesting that there is not an immunological defect that predisposes patients with leprosy to chronic infection. Infection with HCV was not more frequent than in the general adult Brazilian population.
